Series A - Tagworks Pharmaceuticals

Series A - Tagworks Pharmaceuticals

Investment Firm

Overview

Tagworks Pharmaceuticals is a privately held biotech company

Announced Date

Jun 22, 2023

Funding Type

Series A

Highlights

Location

Europe

Social

Investor Lead

Gilde Healthcare

Gilde Healthcare

Gilde Healthcare is a early_stage_venture and late_stage_venture and private_equity firm.

Ysios Capital

Ysios Capital

Ysios Capital is a early_stage_venture and late_stage_venture and post_ipo and venture firm.

Participant Investors

5

Investor Name
Participant InvestorYsios Capital
Participant InvestorNovartis Venture Fund
Participant InvestorLightstone Ventures
Participant InvestorGilde Healthcare
Participant InvestorNew Enterprise Associates

Round Details and Background

Tagworks Pharmaceuticals raised $65000000 on 2023-06-22 in Series A

Tagworks Pharmaceuticals is a privately held biotech company

Company Funding History

2

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Sep 01, 2021
Seed Round - Tagworks Pharmaceuticals
1-undefined
Jun 22, 2023
Series A - Tagworks Pharmaceuticals
7-65.0M

Recent Activity

There is no recent news or activity for this profile.